Detalhe da pesquisa
1.
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.
J Mol Cell Cardiol
; 57: 72-81, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352991
2.
Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis.
Heart Vessels
; 28(5): 667-71, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23180241
3.
A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.
Cell Metab
; 6(4): 294-306, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908558
4.
Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure.
Circ J
; 76(8): 1889-94, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664754
5.
Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice.
J Mol Cell Cardiol
; 51(6): 1026-36, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21964378
6.
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.
Arterioscler Thromb Vasc Biol
; 30(4): 724-32, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20237330
7.
Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world.
Circ J
; 75(5): 1130-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21467658
8.
Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization.
Circ J
; 75(7): 1616-25, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21532182
9.
Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice.
Circulation
; 120(17): 1695-703, 2009 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822807
10.
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.
Am J Pathol
; 175(3): 998-1009, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19679877
11.
Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
Cardiovasc Res
; 78(3): 546-53, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18267957
12.
Cardiac effects of acute administration of a protonophore in a rat model.
J Pharm Pharmacol
; 70(9): 1209-1215, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943452
13.
Akt/protein kinase B promotes organ growth in transgenic mice.
Mol Cell Biol
; 22(8): 2799-809, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11909972
14.
Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
Mol Cell Biol
; 24(14): 6231-40, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15226426
15.
The metabolic profile of a rat model of chronic kidney disease.
PeerJ
; 5: e3352, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560105
16.
Kyoto Congestive Heart Failure (KCHF) study: rationale and design.
ESC Heart Fail
; 4(3): 216-223, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28772047
17.
MicroRNA, emerging role as a biomarker of heart failure.
Circ J
; 75(2): 268-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21206130
18.
Correction for McMullen et al., "Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy".
Mol Cell Biol
; 41(2)2021 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495398
19.
Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Circulation
; 107(12): 1664-70, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12668503
20.
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
Circulation
; 109(24): 3050-5, 2004 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15184287